Medicinal Cannabis Industry Association is pleased to announce that Patty Holmes has been appointed as the new Executive Officer. A pioneer of the Australian medicinal cannabis industry, Patty will succeed Rosemary Richards and assume responsibilities from 1 June 2023.
Rosemary has been instrumental in the establishment and management of the MCIA including governance arrangements, growing the membership base and positioning the MCIA as the peak industry organisation for Australia’s medicinal cannabis industry. Rosemary, through her consulting business, will remain in contact with MCIA for specific projects as appropriate.
Patty brings 15+ years of experience to the position, having worked previously at various pharmaceutical companies, as Chief Operating Officer at Althea and most recently in establishing a consulting company for novel therapeutics. Patty is passionate about improving patient access to medicinal cannabis in a flourishing medicinal cannabis industry and looks forward to further driving membership value.
Peter Crock, MCIA Chair said “MCIA thanks Rosemary for her service and dedication to the organisation, and the cause, and wishes her the best for the future. I look forward to working with Patty to continue MCIA’s important work, building on the tremendous foundation that we have established thanks to Rosemary’s guidance and incredible work capacity and ethic”.
MEDIA CONTACTS
Peter Crock
Chair, MCIA
0419 307 467
Patty Holmes
Executive Officer, MCIA
0408 200 938
About MCIA:
MCIA is the peak industry organisation and voice for Australia’s medicinal cannabis industry. Our focus is on building a legitimate industry that enhances wellbeing through facilitating access to quality Australian medicinal cannabis products for Australian and global patients. MCIA provides stewardship for an economically sustainable and socially responsible industry that is trusted and valued by patients, the medical community and governments. The Australian industry and its products are built on sound science and underpinned by industry processes and standards that ensure patients, the medical community and governments have confidence in the sector and its products.